Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market
Holding ELVN?
Track your performance easily

Enliven Therapeutics (ELVN) Financial Statements

275 Followers

Enliven Therapeutics Financial Overview

Enliven Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.932; its P/E ratio is -11.26; Enliven Therapeutics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.51. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Apr 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -19.72M$ -25.99M$ -24.25M$ -16.72M$ -116.23K
EBITDA$ -18.98M$ -25.91M$ -24.17M$ -17.48M-
Net Income Common Stockholders$ -19.95M$ -22.74M$ -20.77M$ -16.72M$ -116.23K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 312.39M$ 320.50M$ 263.48M$ 277.87M$ 338.86K
Total Assets$ 327.04M$ 342.78M$ 274.04M$ 288.50M$ 1.79M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -312.39M$ -320.50M$ -263.48M$ -277.87M$ -338.86K
Total Liabilities$ 22.11M$ 25.07M$ 12.29M$ 9.51M$ 233.55K
Stockholders Equity$ 304.93M$ 317.71M$ 261.75M$ 278.99M$ 1.56M
Cash Flow-
Free Cash Flow$ -20.44M$ -23.38M$ -15.91M$ -12.14M$ -99.53K
Operating Cash Flow$ -20.43M$ -23.36M$ -15.89M$ -12.05M$ -74.29K
Investing Cash Flow$ -33.66M$ -17.89M$ -35.55M$ -151.52M$ -25.23K
Financing Cash Flow$ 1.81M$ 90.27M$ -425.00K$ -2.82M$ 114.50K
Currency in USD

Enliven Therapeutics Earnings and Revenue History

Enliven Therapeutics Debt to Assets

Enliven Therapeutics Cash Flow

Enliven Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis